Plunging sales of Merck’s blockbuster HPV vaccine in China have caused a sharp fall in the US pharma group’s earnings.
美國制藥集團默克(Merck)的重磅產品HPV疫苗在華銷售額大幅下滑,導致該公司盈利大幅下滑。
? The Financial Times Ltd 2025 FT and 'Financial Times' are trademarks of The Financial Times Ltd.